Oral Tranexamic Acid After Total Knee Arthroplasty
- Sponsor
- Rush University Medical Center
- Study ID
- NCT06894719
- Phase
- PHASE4
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Total Knee Arthroplasty
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- tranexamic acid Oral-Short Arm — DRUG1.95g Tranexamic acid daily for post op days 1 to 3
- tranexamic acid Oral-Long Arm — DRUG1.95g tranexamic acid daily post op days 1-7
- Control group placebo — DRUGPlacebo for 3 days post-op
Study Details
This is a prospective, double-blind, randomized controlled trial evaluating the efficacy of oral tranexamic acid (TXA) in total knee arthroplasty (TKA). The study will assess pain, function, and range of motion (ROM) over a 2-year period, with key evaluations at 6 weeks and 90 days postoperatively. Hypothesis: Patients receiving 1.95g oral TXA for 3 or 7 days post-op will show improved pain, function, and ROM at 6 weeks and 90 days, with similar blood loss and transfusion rates as the control group.
Key Dates
- First listed
- Mar 25, 2025
- Start date
- Jun 1, 2026
- Status verified
- Feb 2026
- Primary completion
- Dec 1, 2026
- Completion
- May 1, 2027
Study Design
- Enrollment
- 351 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Oral-Short Arm: 1.95g TXA daily POD 1-31.95g TXA daily for post operative days 1-3
- Active Comparator: Oral-Long Arm1.95g TXA daily for post operative days 1-7
- Placebo Comparator: Control Group: Placebo for 3 days post-opPlacebo for 3 days post-op
Primary Outcome Measure
Primary endpoint: knee range of motion [ Time Frame: (flexion/extension) at 2 weeks and 6 weeks post op ]
Central Contacts
- Anne DeBenedetti, MSc13124322468
- Marisa Toschi, BS312-432-2455
Related Studies
- Medrol Dosepak for Outpatient Total Knee ArthroplastyPHASE4 · Recruiting · Rush University Medical Center · Oak Brook, Illinois
- Improving Rehabilitation for Veterans After Total Knee Arthroplasty Using Individualized Recovery TrajectoriesRecruiting · VA Office of Research and Development · Aurora, Colorado
- Persona MC vs PS RCT With ROSARecruiting · NYU Langone Health · New York, New York
- Enhanced Recovery After Major Surgery and Chronic Pain for Total Knee ArthroplastyRecruiting · Hospital for Special Surgery, New York · New York, New York